Aptevo Raises $4.5M in Warrant Inducement and PIPE, Adding Significant Dilution

summarizeSummary

Aptevo Therapeutics raised $4.5 million through a warrant inducement and PIPE, issuing millions of new warrants and shares at $4.03 per share, significantly diluting existing holders.

check_boxKey Events · Financing and Capital Events · APVO

• Warrant Inducement and PIPE Closed

  Aptevo closed a $4.5 million financing on August 13, 2026, consisting of a warrant inducement exercise of 254,922 shares at $4.03 and a private placement of up to 861,708 shares at $4.03.

• Massive Warrant Issuance

  The company issued 1,274,610 inducement warrants and 4,308,540 common warrants, all with an exercise price of $4.03, creating potential dilution of over 5.5 million shares.

• Dilution Impact

  With only 1,555,293 shares outstanding before the deal, the new shares and warrants could increase the share count by over 350% if fully exercised.

• Use of Proceeds

  Net proceeds will be used for working capital and general corporate purposes, extending the company's cash runway amid a going concern warning.

auto_awesomeAnalysis · APVO · Life Sciences

Aptevo Therapeutics closed a $4.5 million financing package on August 13, 2026, combining a warrant inducement exercise with a private placement. The deal includes the exercise of 254,922 existing warrants at a reduced price of $4.03, issuance of 1,274,610 inducement warrants, sale of up to 861,708 shares at $4.03, and issuance of 4,308,540 common warrants. The exercise price of $4.03 is above the current stock price of $3.37, but the massive warrant overhang—over 5.5 million shares underlying new warrants—represents substantial potential dilution for a company with only 1.55 million shares outstanding. The company is trading near its 52-week low and has a going concern warning, making this financing a critical survival move but one that heavily dilutes existing shareholders.